Patient management by cyclosporine C2 monitoring: not enough science yet to justify the practice.
Campbell
Scott B
SB
Johnson
David W
DW
D003175:Complement C2 / Q000032:analysis*; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects; D006084:Graft Rejection / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016030:Kidney Transplantation
D003175:Complement C2; D007166:Immunosuppressive Agents; D016572:Cyclosporine